App-Quantinova.ai

MANAGEMENT OF MAJOR ABDOMINAL SURGERY IN AN ADOLESCENT PATIENT WITH SEVERE HAEMOPHILIA A AND FVIII INHIBITOR ON EMICIZUMAB

A. Wilkinson - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

PERIOPERATIVE MANAGEMENT OF PATIENTS WITH HEMOPHILIA (PWH) RECEIVING FITUSIRAN PROPHYLAXIS WITH REDUCED DOSES OF BPA OR FACTOR REPLACEMENT

M. V. Ragni - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

PREDICTIVE MODELLING IDENTIFIES RESPONSE TO FIXED DOSE N8‐GP PROPHYLAXIS IN THE FIRST WEEKS OF TREATMENT AS A PREDICTOR OF LONG‐TERM OUTCOMES

P. Chowdary - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

PROPHYLAXIS VS ON‐DEMAND TREATMENT IN MODERATE HAEMOPHILIA A PATIENTS WITH NO INHIBITORS IN EU5

S. Brown - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

REAL WORLD BLEEDING RATES OVER 7 YEARS OF ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN PATIENTS WITH HEMOPHILIA A AND TARGET JOINTS: AHEAD INTERNATIONAL

M. C. Ozelo - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

Antihemophilic factor

REAL WORLD EXPERIENCE OF PORCINE FVIII USE IN COMPLEX PELVIC SURGERY AND ACQUIRED HAEMOPHILIA A: CASE REPORT AND MULTI‐DISCIPLINARY TEAM REFLECTION.

K. McCloskey - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gynaecological cancer

Prednisolone

REAL‐WORLD CLINICAL OUTCOMES IN PEOPLE FROM ACROSS EUROPE WITH SEVERE HAEMOPHILIA B RECEIVING FIX PROPHYLAXIS: AN ANALYSIS OF CHESS II

T. Burke - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Chronic pain

N/A

REAL‐WORLD EFFICACY OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: A REPORT FROM THE UK HAEMOPHILIA CENTRE DOCTORS’ ORGANISATION

C. Wall - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

REAL‐WORLD SAFETY AND EFFECTIVENESS OF RECOMBINANT B‐DOMAIN–DELETED PORCINE‐SEQUENCE FACTOR VIII FOR ACQUIRED HEMOPHILIA A

W. Miesbach - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

RESULTS FROM A 52‐WEEK, PROSPECTIVE, NONINTERVENTIONAL STUDY OF INDIVIDUALS WITH SEVERE HAEMOPHILIA A RECEIVING PROPHYLAXIS: RATES OF BLEEDING, FVIII USE, AND QUALITY OF LIFE

G. Kenet - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

THE CLINICAL PHENOTYPE OF PATIENTS WITH NON‐SEVERE HEMOPHILIA A AND B

A.-F. Zwagemaker - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

UPTAKE OF EMICIZUMAB FOR PROPHYLAXIS IN CHILDREN WITH SEVERE HAEMOPHILIA A < 12 YEARS OF AGE IN THE UK.

M. Mathias - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

USE OF DESMOPRESSIN IN THE TREATMENT OF BLEEDING IN NON‐SEVERE HEMOPHILIA A

F. R. Kloosterman - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

Desmopressin

WORLD BLEEDING DISORDERS REGISTRY SHOWCASES DISPARITIES IN HEMOPHILIA CARE AROUND THE WORLD

E. Ayoub - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

EXPLORING THE PRESENCE AND IMPACTS OF GUM BLEEDING IN VON WILLEBRANDS DISEASE – WHAT LIES BENEATH THE DATA?

D. Noone - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

DIAGNOSIS AND MANAGEMENT OF ACQUIRED FACTOR XI DEFICIENCY IN SYSTEMIC LUPUS ERYTHEMATOSUS

B. Madan - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

EVALUATION OF THE ISTH‐BAT AND PBQ BLEEDING ASSESSMENT TOOLS IN CHILDREN WITH A SUSPECTED HEREDITARY COAGULATION DISORDER

A.-F. Zwagemaker - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

A SINGLE UK PAEDIATRIC HAEMOPHILIA COMPREHENSIVE CARE CENTRE EXPERIENCE OF A NURSE‐LED HAEMOPHILIA CLINIC FOR FEMALES WITH FACTOR VIII OR IX DEFICIENCY

S. Pool - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

THE USE OF PARAFILM TO PREVENT CVADS INFECTION IN PATIENT WITH SEVERE FACTOR X DEFICIENCY

S. emmitt - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Factor X deficiency

N/A

DIFFERENTIATING JOINT BLEEDING AND HAEMOPHILIA ARTHROPATHY – A QUALITATIVE STUDY

D. J. Hopper - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Filters

45280 Abstracts